论文部分内容阅读
目的观察肝动脉栓塞术(TACE)治疗肝癌的临床疗效。方法选取1997年1月~2008年2月收治肝癌患者150例,均采用TACE治疗并对所有患者均随访。结果通过150例肝癌介入3次TACE以上者50例,占33%;1年以上生存者30例,占20%,10年以上生存者6例,占4%。结论肝癌经TACE术后是一种安全有效的治疗方法,提高了生活质量,延长了患者生命。
Objective To observe the clinical effect of hepatic artery embolization (TACE) in the treatment of liver cancer. Methods From January 1997 to February 2008, 150 patients with hepatocellular carcinoma (HCC) were enrolled. All of them were treated with TACE and all patients were followed up. Results Fifty patients (33%) were involved in three HCCs with TACE more than three times in 150 cases. Thirty cases survived more than one year, accounting for 20%. Six of them survived more than 10 years, accounting for 4%. Conclusion TACE after liver cancer is a safe and effective treatment, which improves the quality of life and prolongs the life of patients.